Wuxi Biologics Cayman Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of WXIBF for the last semiannual is 1.18 B USD, and it's 3.56% lower compared to the previous semiannual. The net income of H2 23 is 156.72 M USD.